Woolley, Josh

The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease

Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L., & Rankin, K. P. (2011) · The Journal of Clinical Psychiatry

Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments

Cited by 549

Intranasal oxytocin selectively modulates social perception, craving, and approach behavior in subjects with alcohol use disorder

Mitchell, J. M., Arcuni, P. A., Weinstein, D., & Woolley, J. D. (2016) · Journal of Addiction Medicine

Neuroendocrine regulation and behaviorSubstance Abuse Treatment and Outcomes

Cited by 82

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption

Morton, E., Sakai, K., Ashtari, A., Pleet, M., Michalak, E. E., & Woolley, J. (2023) · Journal of Psychopharmacology

Psychedelics and Drug StudiesBipolar Disorder and Treatment

Cited by 78

Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis

Agin-Liebes, G., Ekman, E., Anderson, B., Malloy, M., Haas, A., & Woolley, J. (2024) · Journal of Humanistic Psychology

Psychedelics and Drug StudiesReligion, Spirituality, and Psychology

Cited by 51

“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use

DellaCrosse, M., Pleet, M., Morton, E., Ashtari, A., Sakai, K., Woolley, J., & Michalak, E. (2022) · PLOS ONE

Psychedelics and Drug StudiesBipolar Disorder and Treatment

Cited by 28